Genetic susceptibility of urolithiasis: comprehensive results from genome-wide analysis

go back to reference Singh P, Enders FT, Vaughan LE, Bergstralh EJ, Knoedler JJ, Krambeck AE, Lieske JC, Rule AD (2015) Stone composition among first-time symptomatic kidney stone formers in the community. Mayo Clin Proc 90(10):1356–1365CrossRefPubMed Singh P, Enders FT, Vaughan LE, Bergstralh EJ, Knoedler JJ, Krambeck AE, Lieske JC, Rule AD (2015) Stone composition among first-time symptomatic kidney stone formers in the community. Mayo Clin Proc 90(10):1356–1365CrossRefPubMed

go back to reference Coe FL, Worcester EM, Evan AP (2016) Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol 12(9):519–533CrossRefPubMedPubMedCentral Coe FL, Worcester EM, Evan AP (2016) Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol 12(9):519–533CrossRefPubMedPubMedCentral

go back to reference Lede L, Liang Z, Kaiwen X, Xi J, Zhongyu J, Yu L, Hong L, Kunjie W (2022) Does combined lithotripter show superior stone-success rate than ultrasonic or pneumatic device alone during percutaneous nephrolithotrotomy? A meta-analysis. Int J Surg 98:106223. https://doi.org/10.1016/j.ijsu.2021.106223CrossRef Lede L, Liang Z, Kaiwen X, Xi J, Zhongyu J, Yu L, Hong L, Kunjie W (2022) Does combined lithotripter show superior stone-success rate than ultrasonic or pneumatic device alone during percutaneous nephrolithotrotomy? A meta-analysis. Int J Surg 98:106223. https://​doi.​org/​10.​1016/​j.​ijsu.​2021.​106223CrossRef

go back to reference Singh P, Harris PC, Sas DJ, Lieske JC (2022) The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol 18(4):224–240CrossRefPubMed Singh P, Harris PC, Sas DJ, Lieske JC (2022) The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol 18(4):224–240CrossRefPubMed

go back to reference Howles SA, Thakker RV (2020) Genetics of kidney stone disease. Nat Rev Urol 17(7):407–421CrossRefPubMed Howles SA, Thakker RV (2020) Genetics of kidney stone disease. Nat Rev Urol 17(7):407–421CrossRefPubMed

go back to reference Dickson FJ, Sayer JA (2020) Nephrocalcinosis: a review of monogenic causes and insights they provide into this heterogeneous condition. Int J Mol Sci 21(1):369CrossRefPubMedPubMedCentral Dickson FJ, Sayer JA (2020) Nephrocalcinosis: a review of monogenic causes and insights they provide into this heterogeneous condition. Int J Mol Sci 21(1):369CrossRefPubMedPubMedCentral

go back to reference Ehlayel AM, Copelovitch L (2019) Update on dent disease. Pediatr Clin North Am 66(1):169–178CrossRefPubMed Ehlayel AM, Copelovitch L (2019) Update on dent disease. Pediatr Clin North Am 66(1):169–178CrossRefPubMed

go back to reference De Matteis MA, Staiano L, Emma F, Devuyst O (2017) The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2. Nat Rev Nephrol 13(8):455–470CrossRefPubMed De Matteis MA, Staiano L, Emma F, Devuyst O (2017) The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2. Nat Rev Nephrol 13(8):455–470CrossRefPubMed

go back to reference Rungroj N, Nettuwakul C, Sawasdee N, Sangnual S, Deejai N, Misgar RA, Pasena A, Khositseth S, Kirdpon S, Sritippayawan S, Vasuvattakul S, Yenchitsomanus PT (2018) Distal renal tubular acidosis caused by tryptophan-aspartate repeat domain 72 (WDR72) mutations. Clin Genet 94(5):409–418CrossRefPubMed Rungroj N, Nettuwakul C, Sawasdee N, Sangnual S, Deejai N, Misgar RA, Pasena A, Khositseth S, Kirdpon S, Sritippayawan S, Vasuvattakul S, Yenchitsomanus PT (2018) Distal renal tubular acidosis caused by tryptophan-aspartate repeat domain 72 (WDR72) mutations. Clin Genet 94(5):409–418CrossRefPubMed

go back to reference Jobst-Schwan T, Klämbt V, Tarsio M, Heneghan JF, Majmundar AJ, Shril S, Buerger F, Ottlewski I, Shmukler BE, Topaloglu R, Hashmi S, Hafeez F, Emma F, Greco M, Laube GF, Fathy HM, Pohl M, Gellermann J, Milosevic D, Baum MA, Mane S, Lifton RP, Kane PM, Alper SL, Hildebrandt F (2020) Whole exome sequencing identified ATP6V1C2 as a novel candidate gene for recessive distal renal tubular acidosis. Kidney Int 97(3):567–579CrossRefPubMed Jobst-Schwan T, Klämbt V, Tarsio M, Heneghan JF, Majmundar AJ, Shril S, Buerger F, Ottlewski I, Shmukler BE, Topaloglu R, Hashmi S, Hafeez F, Emma F, Greco M, Laube GF, Fathy HM, Pohl M, Gellermann J, Milosevic D, Baum MA, Mane S, Lifton RP, Kane PM, Alper SL, Hildebrandt F (2020) Whole exome sequencing identified ATP6V1C2 as a novel candidate gene for recessive distal renal tubular acidosis. Kidney Int 97(3):567–579CrossRefPubMed

go back to reference Enerbäck S, Nilsson D, Edwards N, Heglind M, Alkanderi S, Ashton E, Deeb A, Kokash FEB, Bakhsh ARA, Van’t Hoff W, Walsh SB, D’Arco F, Daryadel A, Bourgeois S, Wagner CA, Kleta R, Bockenhauer D, Sayer JA (2018) Acidosis and deafness in patients with recessive mutations in FOXI1. J Am Soc Nephrol 29(3):1041–1048CrossRefPubMed Enerbäck S, Nilsson D, Edwards N, Heglind M, Alkanderi S, Ashton E, Deeb A, Kokash FEB, Bakhsh ARA, Van’t Hoff W, Walsh SB, D’Arco F, Daryadel A, Bourgeois S, Wagner CA, Kleta R, Bockenhauer D, Sayer JA (2018) Acidosis and deafness in patients with recessive mutations in FOXI1. J Am Soc Nephrol 29(3):1041–1048CrossRefPubMed

go back to reference D’Ambrosio V, Azzarà A, Sangiorgi E, Gurrieri F, Hess B, Gambaro G, Ferraro PM (2021) Results of a gene panel approach in a cohort of patients with incomplete distal renal tubular acidosis and nephrolithiasis. Kidney Blood Press Res 46(4):469–474CrossRefPubMed D’Ambrosio V, Azzarà A, Sangiorgi E, Gurrieri F, Hess B, Gambaro G, Ferraro PM (2021) Results of a gene panel approach in a cohort of patients with incomplete distal renal tubular acidosis and nephrolithiasis. Kidney Blood Press Res 46(4):469–474CrossRefPubMed

go back to reference Bourgeois S, Bettoni C, Baron S, Wagner CA (2018) Haploinsufficiency of the mouse Atp6v1b1 gene leads to a mild acid-base disturbance with implications for kidney stone disease. Cell Physiol Biochem 47(3):1095–1107CrossRefPubMed Bourgeois S, Bettoni C, Baron S, Wagner CA (2018) Haploinsufficiency of the mouse Atp6v1b1 gene leads to a mild acid-base disturbance with implications for kidney stone disease. Cell Physiol Biochem 47(3):1095–1107CrossRefPubMed

go back to reference Bergwitz C, Miyamoto KI (2019) Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy. Pflugers Arch 471(1):149–163CrossRefPubMed Bergwitz C, Miyamoto KI (2019) Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy. Pflugers Arch 471(1):149–163CrossRefPubMed

go back to reference De Paolis E, Scaglione GL, De Bonis M, Minucci A, Capoluongo E (2019) CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype. Clin Chem Lab Med 57(11):1650–1667CrossRefPubMed De Paolis E, Scaglione GL, De Bonis M, Minucci A, Capoluongo E (2019) CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype. Clin Chem Lab Med 57(11):1650–1667CrossRefPubMed

go back to reference Amar A, Majmundar AJ, Ullah I, Afzal A, Braun DA, Shril S, Daga A, Jobst-Schwan T, Ahmad M, Sayer JA, Gee HY, Halbritter J, Knöpfel T, Hernando N, Werner A, Wagner C, Khaliq S, Hildebrandt F (2019) Gene panel sequencing identifies a likely monogenic cause in 7% of 235 Pakistani families with nephrolithiasis. Hum Genet 138(3):211–219CrossRefPubMedPubMedCentral Amar A, Majmundar AJ, Ullah I, Afzal A, Braun DA, Shril S, Daga A, Jobst-Schwan T, Ahmad M, Sayer JA, Gee HY, Halbritter J, Knöpfel T, Hernando N, Werner A, Wagner C, Khaliq S, Hildebrandt F (2019) Gene panel sequencing identifies a likely monogenic cause in 7% of 235 Pakistani families with nephrolithiasis. Hum Genet 138(3):211–219CrossRefPubMedPubMedCentral

go back to reference Kang SJ, Lee R, Kim HS (2019) Infantile hypercalcemia with novel compound heterozygous mutation in SLC34A1 encoding renal sodium-phosphate cotransporter 2a: a case report. Ann Pediatr Endocrinol Metab 24(1):64–67CrossRefPubMedPubMedCentral Kang SJ, Lee R, Kim HS (2019) Infantile hypercalcemia with novel compound heterozygous mutation in SLC34A1 encoding renal sodium-phosphate cotransporter 2a: a case report. Ann Pediatr Endocrinol Metab 24(1):64–67CrossRefPubMedPubMedCentral

go back to reference Policastro LJ, Saggi SJ, Goldfarb DS, Weiss JP (2018) Personalized intervention in monogenic stone formers. J Urol 199(3):623–632CrossRefPubMed Policastro LJ, Saggi SJ, Goldfarb DS, Weiss JP (2018) Personalized intervention in monogenic stone formers. J Urol 199(3):623–632CrossRefPubMed

go back to reference Martin-Higueras C, Torres A, Salido E (2017) Molecular therapy of primary hyperoxaluria. J Inherit Metab Dis 40(4):481–489CrossRefPubMed Martin-Higueras C, Torres A, Salido E (2017) Molecular therapy of primary hyperoxaluria. J Inherit Metab Dis 40(4):481–489CrossRefPubMed

go back to reference Singh P, Chebib FT, Cogal AG, Gavrilov DK, Harris PC, Lieske JC (2020) Pyridoxine responsiveness in a Type 1 primary hyperoxaluria patient with a rare (Atypical) AGXT gene mutation. Kidney Int Rep 5(6):955–958CrossRefPubMedPubMedCentral Singh P, Chebib FT, Cogal AG, Gavrilov DK, Harris PC, Lieske JC (2020) Pyridoxine responsiveness in a Type 1 primary hyperoxaluria patient with a rare (Atypical) AGXT gene mutation. Kidney Int Rep 5(6):955–958CrossRefPubMedPubMedCentral

go back to reference Garrelfs SF, Rumsby G, Peters-Sengers H, Erger F, Groothoff JW, Beck BB, Oosterveld MJS, Pelle A, Neuhaus T, Adams B, Cochat P, Salido E, Lipkin GW, Hoppe B, Hulton SA, OxalEurope Consortium (2019) Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up. Kidney Int. 96(6):1389–1399CrossRefPubMed Garrelfs SF, Rumsby G, Peters-Sengers H, Erger F, Groothoff JW, Beck BB, Oosterveld MJS, Pelle A, Neuhaus T, Adams B, Cochat P, Salido E, Lipkin GW, Hoppe B, Hulton SA, OxalEurope Consortium (2019) Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up. Kidney Int. 96(6):1389–1399CrossRefPubMed

go back to reference Greed L, Willis F, Johnstone L, Teo S, Belostotsky R, Frishberg Y, Pitt J (2018) Metabolite diagnosis of primary hyperoxaluria type 3. Pediatr Nephrol 33(8):1443–1446CrossRefPubMed Greed L, Willis F, Johnstone L, Teo S, Belostotsky R, Frishberg Y, Pitt J (2018) Metabolite diagnosis of primary hyperoxaluria type 3. Pediatr Nephrol 33(8):1443–1446CrossRefPubMed

go back to reference Weigert A, Martin-Higueras C, Hoppe B (2018) Novel therapeutic approaches in primary hyperoxaluria. Expert Opin Emerg Drugs 23(4):349–357CrossRefPubMed Weigert A, Martin-Higueras C, Hoppe B (2018) Novel therapeutic approaches in primary hyperoxaluria. Expert Opin Emerg Drugs 23(4):349–357CrossRefPubMed

go back to reference Li Y, Lu X, Yu Z, Wang H, Gao B (2023) Meta-data analysis of kidney stone disease highlights ATP1A1 involvement in renal crystal formation. Redox Biol 61:102648CrossRefPubMedPubMedCentral Li Y, Lu X, Yu Z, Wang H, Gao B (2023) Meta-data analysis of kidney stone disease highlights ATP1A1 involvement in renal crystal formation. Redox Biol 61:102648CrossRefPubMedPubMedCentral

go back to reference Ye QL, Wang DM, Wang X, Zhang ZQ, Tian QX, Feng SY, Zhang ZH, Yu DX, Ding DM, Xie DD (2021) Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury. Chem Biol Interact 25(347):109605CrossRef Ye QL, Wang DM, Wang X, Zhang ZQ, Tian QX, Feng SY, Zhang ZH, Yu DX, Ding DM, Xie DD (2021) Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury. Chem Biol Interact 25(347):109605CrossRef

go back to reference Wang X, Zhang Y, Han S, Chen H, Chen C, Ji L, Gao B (2020) Overexpression of miR-30c-5p reduces cellular cytotoxicity and inhibits the formation of kidney stones through ATG5. Int J Mol Med 45(2):375–384PubMed Wang X, Zhang Y, Han S, Chen H, Chen C, Ji L, Gao B (2020) Overexpression of miR-30c-5p reduces cellular cytotoxicity and inhibits the formation of kidney stones through ATG5. Int J Mol Med 45(2):375–384PubMed

go back to reference Wang XF, Zhang BH, Lu XQ, Wang RQ (2019) Gastrin-releasing peptide receptor gene silencing inhibits the development of the epithelial-mesenchymal transition and formation of a calcium oxalate crystal in renal tubular epithelial cells in mice with kidney stones via the PI3K/Akt signaling pathway. J Cell Physiol 234(2):1567–1577CrossRefPubMed Wang XF, Zhang BH, Lu XQ, Wang RQ (2019) Gastrin-releasing peptide receptor gene silencing inhibits the development of the epithelial-mesenchymal transition and formation of a calcium oxalate crystal in renal tubular epithelial cells in mice with kidney stones via the PI3K/Akt signaling pathway. J Cell Physiol 234(2):1567–1577CrossRefPubMed

go back to reference Sayer JA (2017) Progress in understanding the genetics of calcium-containing nephrolithiasis. J Am Soc Nephrol 28(3):748–759CrossRefPubMed Sayer JA (2017) Progress in understanding the genetics of calcium-containing nephrolithiasis. J Am Soc Nephrol 28(3):748–759CrossRefPubMed

go back to reference Xi J, Chen Y, Jing J, Zhang Y, Liang C, Hao Z, Zhang L (2019) Sirtuin 3 suppresses the formation of renal calcium oxalate crystals through promoting M2 polarization of macrophages. J Cell Physiol 234(7):11463–11473CrossRefPubMed Xi J, Chen Y, Jing J, Zhang Y, Liang C, Hao Z, Zhang L (2019) Sirtuin 3 suppresses the formation of renal calcium oxalate crystals through promoting M2 polarization of macrophages. J Cell Physiol 234(7):11463–11473CrossRefPubMed

go back to reference Lu H, Sun X, Jia M, Sun F, Zhu J, Chen X, Chen K, Jiang K (2021) Rosiglitazone suppresses renal crystal deposition by ameliorating tubular injury resulted from oxidative stress and inflammatory response via promoting the Nrf2/HO-1 pathway and shifting macrophage polarization. Oxid Med Cell Longev 14(2021):5527137 Lu H, Sun X, Jia M, Sun F, Zhu J, Chen X, Chen K, Jiang K (2021) Rosiglitazone suppresses renal crystal deposition by ameliorating tubular injury resulted from oxidative stress and inflammatory response via promoting the Nrf2/HO-1 pathway and shifting macrophage polarization. Oxid Med Cell Longev 14(2021):5527137

go back to reference Sun L, Zou LX, Wang J, Chen T, Han YC, Zhu DD, Zhuo SC (2018) Mucin 4 gene silencing reduces oxidative stress and calcium oxalate crystal formation in renal tubular epithelial cells through the extracellular signal-regulated kinase signaling pathway in nephrolithiasis rat model. Kidney Blood Press Res 43(3):820–835CrossRefPubMed Sun L, Zou LX, Wang J, Chen T, Han YC, Zhu DD, Zhuo SC (2018) Mucin 4 gene silencing reduces oxidative stress and calcium oxalate crystal formation in renal tubular epithelial cells through the extracellular signal-regulated kinase signaling pathway in nephrolithiasis rat model. Kidney Blood Press Res 43(3):820–835CrossRefPubMed

go back to reference Sun Y, Liu Y, Guan X, Kang J, Wang X, Liu Q, Li D, Xu H, Tao Z, Deng Y (2020) Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF-κB and NLRP3 inflammasome. IUBMB Life 72(5):1065–1074CrossRefPubMed Sun Y, Liu Y, Guan X, Kang J, Wang X, Liu Q, Li D, Xu H, Tao Z, Deng Y (2020) Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF-κB and NLRP3 inflammasome. IUBMB Life 72(5):1065–1074CrossRefPubMed

go back to reference Võsa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B, Kirsten H, Saha A, Kreuzhuber R, Yazar S, Brugge H, Oelen R, de Vries DH, van der Wijst MGP, Kasela S, Pervjakova N, Alves I, Favé MJ, Agbessi M, Christiansen MW, Jansen R, Seppälä I, Tong L, Teumer A, Schramm K, Hemani G, Verlouw J, Yaghootkar H, Sönmez Flitman R, Brown A, Kukushkina V, Kalnapenkis A, Rüeger S, Porcu E, Kronberg J, Kettunen J, Lee B, Zhang F, Qi T, Hernandez JA, Arindrarto W, Beutner F, BIOS Consortium, i2QTL Consortium, Dmitrieva J, Elansary M, Fairfax BP, Georges M, Heijmans BT, Hewitt AW, Kähönen M, Kim Y, Knight JC, Kovacs P, Krohn K, Li S, Loeffler M, Marigorta UM, Mei H, Momozawa Y, Müller-Nurasyid M, Nauck M, Nivard MG, Penninx BWJH, Pritchard JK, Raitakari OT, Rotzschke O, Slagboom EP, Stehouwer CDA, Stumvoll M, Sullivan P, ‘t Hoen PAC, Thiery J, Tönjes A, van Dongen J, van Iterson M, Veldink JH, Völker U, Warmerdam R, Wijmenga C, Swertz M, Andiappan A, Montgomery GW, Ripatti S, Perola M, Kutalik Z, Dermitzakis E, Bergmann S, Frayling T, van Meurs J, Prokisch H, Ahsan H, Pierce BL, Lehtimäki T, Boomsma DI, Psaty BM, Gharib SA, Awadalla P, Milani L, Ouwehand WH, Downes K, Stegle O, Battle A, Visscher PM, Yang J, Scholz M, Powell J, Gibson G, Esko T, Franke L (2021) Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet 53(9):1300–1310CrossRefPubMedPubMedCentral Võsa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B, Kirsten H, Saha A, Kreuzhuber R, Yazar S, Brugge H, Oelen R, de Vries DH, van der Wijst MGP, Kasela S, Pervjakova N, Alves I, Favé MJ, Agbessi M, Christiansen MW, Jansen R, Seppälä I, Tong L, Teumer A, Schramm K, Hemani G, Verlouw J, Yaghootkar H, Sönmez Flitman R, Brown A, Kukushkina V, Kalnapenkis A, Rüeger S, Porcu E, Kronberg J, Kettunen J, Lee B, Zhang F, Qi T, Hernandez JA, Arindrarto W, Beutner F, BIOS Consortium, i2QTL Consortium, Dmitrieva J, Elansary M, Fairfax BP, Georges M, Heijmans BT, Hewitt AW, Kähönen M, Kim Y, Knight JC, Kovacs P, Krohn K, Li S, Loeffler M, Marigorta UM, Mei H, Momozawa Y, Müller-Nurasyid M, Nauck M, Nivard MG, Penninx BWJH, Pritchard JK, Raitakari OT, Rotzschke O, Slagboom EP, Stehouwer CDA, Stumvoll M, Sullivan P, ‘t Hoen PAC, Thiery J, Tönjes A, van Dongen J, van Iterson M, Veldink JH, Völker U, Warmerdam R, Wijmenga C, Swertz M, Andiappan A, Montgomery GW, Ripatti S, Perola M, Kutalik Z, Dermitzakis E, Bergmann S, Frayling T, van Meurs J, Prokisch H, Ahsan H, Pierce BL, Lehtimäki T, Boomsma DI, Psaty BM, Gharib SA, Awadalla P, Milani L, Ouwehand WH, Downes K, Stegle O, Battle A, Visscher PM, Yang J, Scholz M, Powell J, Gibson G, Esko T, Franke L (2021) Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet 53(9):1300–1310CrossRefPubMedPubMedCentral

go back to reference Elsworth B, Lyon M, Alexander T, Liu Yi, Matthews P, Hallett J, Bates P, Palmer Tom, Haberland V, Smith GD, Zheng J, Haycock P, Gaunt TR, Hemani G (2020) The MRC IEU OpenGWAS data infrastructure. bioRxiv 08(10):244293 Elsworth B, Lyon M, Alexander T, Liu Yi, Matthews P, Hallett J, Bates P, Palmer Tom, Haberland V, Smith GD, Zheng J, Haycock P, Gaunt TR, Hemani G (2020) The MRC IEU OpenGWAS data infrastructure. bioRxiv 08(10):244293

go back to reference Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, Tan VY, Yarmolinsky J, Shihab HA, Timpson NJ, Evans DM, Relton C, Martin RM, Davey Smith G, Gaunt TR, Haycock PC (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 30(7):e34408CrossRef Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, Tan VY, Yarmolinsky J, Shihab HA, Timpson NJ, Evans DM, Relton C, Martin RM, Davey Smith G, Gaunt TR, Haycock PC (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 30(7):e34408CrossRef

go back to reference Lyon M, Andrews SJ, Elsworth B, Gaunt TR, Hemani G, Marcora E (2020) The variant call format provides efficient and robust storage of GWAS summary statistics. bioRxiv 4:280 Lyon M, Andrews SJ, Elsworth B, Gaunt TR, Hemani G, Marcora E (2020) The variant call format provides efficient and robust storage of GWAS summary statistics. bioRxiv 4:280

go back to reference Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, Loukola A, Lahtela E, Mattsson H, Laiho P, Della Briotta Parolo P, Lehisto AA, Kanai M, Mars N, Rämö J, Kiiskinen T, Heyne HO, Veerapen K, Rüeger S, Lemmelä S, Zhou W, Ruotsalainen S, Pärn K, Hiekkalinna T, Koskelainen S, Paajanen T, Llorens V, Gracia-Tabuenca J, Siirtola H, Reis K, Elnahas AG, Sun B, Foley CN, Aalto-Setälä K, Alasoo K, Arvas M, Auro K, Biswas S, Bizaki-Vallaskangas A, Carpen O, Chen CY, Dada OA, Ding Z, Ehm MG, Eklund K, Färkkilä M, Finucane H, Ganna A, Ghazal A, Graham RR, Green EM, Hakanen A, Hautalahti M, Hedman ÅK, Hiltunen M, Hinttala R, Hovatta I, Hu X, Huertas-Vazquez A, Huilaja L, Hunkapiller J, Jacob H, Jensen JN, Joensuu H, John S, Julkunen V, Jung M, Junttila J, Kaarniranta K, Kähönen M, Kajanne R, Kallio L, Kälviäinen R, Kaprio J; FinnGen; Kerimov N, Kettunen J, Kilpeläinen E, Kilpi T, Klinger K, Kosma VM, Kuopio T, Kurra V, Laisk T, Laukkanen J, Lawless N, Liu A, Longerich S, Mägi R, Mäkelä J, Mäkitie A, Malarstig A, Mannermaa A, Maranville J, Matakidou A, Meretoja T, Mozaffari SV, Niemi MEK, Niemi M, Niiranen T, O Donnell CJ, Obeidat ME, Okafo G, Ollila HM, Palomäki A, Palotie T, Partanen J, Paul DS, Pelkonen M, Pendergrass RK, Petrovski S, Pitkäranta A, Platt A, Pulford D, Punkka E, Pussinen P, Raghavan N, Rahimov F, Rajpal D, Renaud NA, Riley-Gillis B, Rodosthenous R, Saarentaus E, Salminen A, Salminen E, Salomaa V, Schleutker J, Serpi R, Shen HY, Siegel R, Silander K, Siltanen S, Soini S, Soininen H, Sul JH, Tachmazidou I, Tasanen K, Tienari P, Toppila-Salmi S, Tukiainen T, Tuomi T, Turunen JA, Ulirsch JC, Vaura F, Virolainen P, Waring J, Waterworth D, Yang R, Nelis M, Reigo A, Metspalu A, Milani L, Esko T, Fox C, Havulinna AS, Perola M, Ripatti S, Jalanko A, Laitinen T, Mäkelä TP, Plenge R, McCarthy M, Runz H, Daly MJ, Palotie A (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508-518.https://doi.org/10.1038/s41586-022-05473-8. Epub 2023 Jan 18. Erratum in: Nature. 2023 Feb 24;: PMID: 36653562; PMCID: PMC9849126CrossRefPubMedPubMedCentral Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, Loukola A, Lahtela E, Mattsson H, Laiho P, Della Briotta Parolo P, Lehisto AA, Kanai M, Mars N, Rämö J, Kiiskinen T, Heyne HO, Veerapen K, Rüeger S, Lemmelä S, Zhou W, Ruotsalainen S, Pärn K, Hiekkalinna T, Koskelainen S, Paajanen T, Llorens V, Gracia-Tabuenca J, Siirtola H, Reis K, Elnahas AG, Sun B, Foley CN, Aalto-Setälä K, Alasoo K, Arvas M, Auro K, Biswas S, Bizaki-Vallaskangas A, Carpen O, Chen CY, Dada OA, Ding Z, Ehm MG, Eklund K, Färkkilä M, Finucane H, Ganna A, Ghazal A, Graham RR, Green EM, Hakanen A, Hautalahti M, Hedman ÅK, Hiltunen M, Hinttala R, Hovatta I, Hu X, Huertas-Vazquez A, Huilaja L, Hunkapiller J, Jacob H, Jensen JN, Joensuu H, John S, Julkunen V, Jung M, Junttila J, Kaarniranta K, Kähönen M, Kajanne R, Kallio L, Kälviäinen R, Kaprio J; FinnGen; Kerimov N, Kettunen J, Kilpeläinen E, Kilpi T, Klinger K, Kosma VM, Kuopio T, Kurra V, Laisk T, Laukkanen J, Lawless N, Liu A, Longerich S, Mägi R, Mäkelä J, Mäkitie A, Malarstig A, Mannermaa A, Maranville J, Matakidou A, Meretoja T, Mozaffari SV, Niemi MEK, Niemi M, Niiranen T, O Donnell CJ, Obeidat ME, Okafo G, Ollila HM, Palomäki A, Palotie T, Partanen J, Paul DS, Pelkonen M, Pendergrass RK, Petrovski S, Pitkäranta A, Platt A, Pulford D, Punkka E, Pussinen P, Raghavan N, Rahimov F, Rajpal D, Renaud NA, Riley-Gillis B, Rodosthenous R, Saarentaus E, Salminen A, Salminen E, Salomaa V, Schleutker J, Serpi R, Shen HY, Siegel R, Silander K, Siltanen S, Soini S, Soininen H, Sul JH, Tachmazidou I, Tasanen K, Tienari P, Toppila-Salmi S, Tukiainen T, Tuomi T, Turunen JA, Ulirsch JC, Vaura F, Virolainen P, Waring J, Waterworth D, Yang R, Nelis M, Reigo A, Metspalu A, Milani L, Esko T, Fox C, Havulinna AS, Perola M, Ripatti S, Jalanko A, Laitinen T, Mäkelä TP, Plenge R, McCarthy M, Runz H, Daly MJ, Palotie A (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508-518.https://​doi.​org/​10.​1038/​s41586-022-05473-8. Epub 2023 Jan 18. Erratum in: Nature. 2023 Feb 24;: PMID: 36653562; PMCID: PMC9849126CrossRefPubMedPubMedCentral

go back to reference Lin L, Wang W, Xiao K, Guo X, Zhou L (2023) Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia. J Endocrinol Invest 46(10):2095–2102. https://doi.org/10.1007/s40618-023-02060-0CrossRefPubMed Lin L, Wang W, Xiao K, Guo X, Zhou L (2023) Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia. J Endocrinol Invest 46(10):2095–2102. https://​doi.​org/​10.​1007/​s40618-023-02060-0CrossRefPubMed

go back to reference Lede L, Kang N, Liyuan X, Liao P, Xiang L (2024) SGLT2 inhibition and three urological cancers: Up-to-date results. Diabetes Metab Res Rev. https://doi.org/10.1002/dmrr.3797CrossRef Lede L, Kang N, Liyuan X, Liao P, Xiang L (2024) SGLT2 inhibition and three urological cancers: Up-to-date results. Diabetes Metab Res Rev. https://​doi.​org/​10.​1002/​dmrr.​3797CrossRef

go back to reference Lede L, Yaxiong T, Kang N, Xiang L, Xu H (2024) Investigating the causal associations between metabolic biomarkers and the risk of kidney cancer. Commun Biol. https://doi.org/10.1038/s42003-024-06114-8CrossRef Lede L, Yaxiong T, Kang N, Xiang L, Xu H (2024) Investigating the causal associations between metabolic biomarkers and the risk of kidney cancer. Commun Biol. https://​doi.​org/​10.​1038/​s42003-024-06114-8CrossRef

go back to reference Canela VH, Bledsoe SB, Lingeman JE, Gerber G, Worcester EM, El-Achkar TM, Williams JC Jr (2021) Demineralization and sectioning of human kidney stones: a molecular investigation revealing the spatial heterogeneity of the stone matrix. Physiol Rep 9(1):e14658CrossRefPubMedPubMedCentral Canela VH, Bledsoe SB, Lingeman JE, Gerber G, Worcester EM, El-Achkar TM, Williams JC Jr (2021) Demineralization and sectioning of human kidney stones: a molecular investigation revealing the spatial heterogeneity of the stone matrix. Physiol Rep 9(1):e14658CrossRefPubMedPubMedCentral

go back to reference Grams ME, Surapaneni A, Chen J, Zhou L, Yu Z, Dutta D, Welling PA, Chatterjee N, Zhang J, Arking DE, Chen TK, Rebholz CM, Yu B, Schlosser P, Rhee EP, Ballantyne CM, Boerwinkle E, Lutsey PL, Mosley T, Feldman HI, Dubin RF, Ganz P, Lee H, Zheng Z, Coresh J (2021) Proteins Associated with Risk of Kidney Function Decline in the General Population. J Am Soc Nephrol 32(9):2291–2302CrossRefPubMedPubMedCentral Grams ME, Surapaneni A, Chen J, Zhou L, Yu Z, Dutta D, Welling PA, Chatterjee N, Zhang J, Arking DE, Chen TK, Rebholz CM, Yu B, Schlosser P, Rhee EP, Ballantyne CM, Boerwinkle E, Lutsey PL, Mosley T, Feldman HI, Dubin RF, Ganz P, Lee H, Zheng Z, Coresh J (2021) Proteins Associated with Risk of Kidney Function Decline in the General Population. J Am Soc Nephrol 32(9):2291–2302CrossRefPubMedPubMedCentral

go back to reference Kiernan E, Surapaneni A, Zhou L, Schlosser P, Walker KA, Rhee EP, Ballantyne CM, Deo R, Dubin RF, Ganz P, Coresh J, Grams ME (2023) Alterations in the circulating proteome associated with albuminuria. J Am Soc Nephrol. https://doi.org/10.1681/ASN.0000000000000108CrossRefPubMed Kiernan E, Surapaneni A, Zhou L, Schlosser P, Walker KA, Rhee EP, Ballantyne CM, Deo R, Dubin RF, Ganz P, Coresh J, Grams ME (2023) Alterations in the circulating proteome associated with albuminuria. J Am Soc Nephrol. https://​doi.​org/​10.​1681/​ASN.​0000000000000108​CrossRefPubMed

go back to reference Hara-Kuge S, Ohkura T, Ideo H, Shimada O, Atsumi S, Yamashita K (2002) Involvement of VIP36 in intracellular transport and secretion of glycoproteins in polarized Madin-Darby canine kidney (MDCK) cells. J Biol Chem 277(18):16332–16339CrossRefPubMed Hara-Kuge S, Ohkura T, Ideo H, Shimada O, Atsumi S, Yamashita K (2002) Involvement of VIP36 in intracellular transport and secretion of glycoproteins in polarized Madin-Darby canine kidney (MDCK) cells. J Biol Chem 277(18):16332–16339CrossRefPubMed